1345 studies found for:    atrial fibrillation
Show Display Options
Rank Status Study
21 Unknown  Identification of Genetic, Biochemical and Hormonal Factors Contributing to Atrial Fibrillation
Condition: Atrial Fibrillation
Intervention:
22 Recruiting Atrial Fibrillation Progression Trial
Condition: Atrial Fibrillation
Interventions: Device: Left Atrial Ablation (Carto® 3, Carto® XP System, or Carto® RMT and ThermoCool®);   Drug: Rate or Rhythm Control Therapy
23 Completed Nifedipine vs Telmisartan on Prevention of Atrial Fibrillation (AF) Recurrence in Hypertensive Patients With AF
Condition: Atrial Fibrillation
Interventions: Drug: Nifedipine,;   Drug: Telmisartan
24 Terminated The Assessment of Oxidative Stress Markers and the Development of Atrial Fibrillation After Cardiac Surgery
Condition: Atrial Fibrillation
Intervention:
25 Active, not recruiting Reasons for Variations in Health Related Quality of Life and Symptom Burden in Patients With Atrial Fibrillation
Conditions: Arrhythmias, Cardiac;   Heart Failure, Systolic;   Atrial Fibrillation
Intervention:
26 Unknown  Suppression Of Atrial Fibrillation With Ranolazine After Cardiac Surgery
Condition: Heart; Dysfunction Postoperative, Cardiac Surgery
Intervention: Other: Atrial fibrillation
27 Completed Trial to Investigate the Efficacy of Olmesartan in Paroxysmal Atrial Fibrillation
Conditions: Heart Disease;   Arrhythmia;   Atrial Fibrillation
Intervention: Drug: Olmesartan
28 Unknown  Cardioversion vs. Catheter Ablation for Persistent Atrial Fibrillation
Condition: Atrial Fibrillation
Interventions: Procedure: catheter ablation;   Procedure: external electric cardioversion
29 Completed
Has Results
International Registry on Cardioversion of Atrial Fibrillation (MK-6621-051)
Condition: Atrial Fibrillation
Intervention:
30 Recruiting TOCCASTAR - TactiCath Contact Force Ablation Catheter Study for Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation
Intervention: Device: Catheter ablation for the treatment of paroxysmal atrial fibrillation
31 Terminated Atrial Fibrillation: Ablation or Surgical Treatment II: FAST II
Condition: Paroxysmal Atrial Fibrillation.
Interventions: Procedure: Percutaneous radiofrequency catheter ablation;   Procedure: Mini invasive thoracoscopic radiofrequency ablation
32 Suspended Persistent Atrial Fibrillation Ablation Trial
Condition: Atrial Fibrillation
Interventions: Procedure: Surgical AF ablation;   Procedure: Percutaneous AF ablation
33 Completed A Study of the Efficacy and Safety of Vernakalant Hydrochloride (MK-6621) in Patients With Atrial Fibrillation (MK-6621-010 AM4)
Condition: Atrial Fibrillation
Interventions: Drug: vernakalant hydrochloride;   Drug: Placebo to vernakalent hydrochloride
34 Completed
Has Results
A Clinical Study of the Arctic Front Cryoablation Balloon for the Treatment of Paroxysmal Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation
Interventions: Device: Arctic Front® Cryoablation Catheter;   Drug: Flecainide or Sotalol or Propafenone
35 Completed Detection of Occult Paroxysmal Atrial Fibrillation After Stroke Using Prolonged Ambulatory Cardiac Monitoring
Conditions: Stroke;   Atrial Fibrillation
Intervention: Other: Mobile cardiac rhythm monitoring
36 Completed Atrial Fibrillation and Congestive Heart Failure Trial
Conditions: Atrial Fibrillation;   Congestive Heart Failure
Interventions: Other: Rate vs rhythm control strategies for atrial fibrillation;   Other: Rate vs rhythm control strategies in atrial fibrillation
37 Recruiting Use of the Hansen Medical System in Patients With Paroxysmal Atrial Fibrillation
Condition: Paroxysmal Atrial Fibrillation
Intervention: Device: Ablation
38 Active, not recruiting 30-Day Cardiac Event Monitor Belt for Recording Atrial Fibrillation After a Cerebral Ischemic Event
Conditions: Stroke;   Transient Ischemic Attack;   Atrial Fibrillation;   Atrial Flutter
Interventions: Device: a 30-day ambulatory cardiac event monitor;   Device: 24-hour Holter
39 Recruiting Feasibility Testing of the Alert for Atrial Fibrillation Program
Condition: Atrial Fibrillation
Intervention: Behavioral: Alert for Atrial Fibrillation Program
40 Terminated EPLERAF-Study: Eplerenone in the Prevention of Atrial Fibrillation Recurrences After Cardioversion
Condition: Atrial Fibrillation
Interventions: Drug: Eplerenone;   Drug: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years